In conclusion, the metabolic profiles associated with MetS underwent significant alterations, with short-term VLCD treatment effectively regulating characteristic metabolites involved in energy metabolism, lipid metabolism, insulin sensitivity, inflammation, oxidative stress, cell signaling, and neurotransmitter-related pathways. Here, INS is linked to metabolic syndrome.